Advertisement

Spinal Tech

Advertisement

The Star Tribune published a special report on Medtronic's Infuse studies on April 10, examining the FDA studies and lawsuits against the company, but ending on CEO Omar Ishrak's plans to expand the marketshare for biografts using Infuse.

Advertisement